Management of fibrosis: the mesenchymal stromal cells breakthrough - Test2 - elhamkhani - TriplyDB

Management of fibrosis: the mesenchymal stromal cells breakthrough

Management of fibrosis: the mesenchymal stromal cells breakthrough

http://www.wikidata.org/entity/Q26827231

about

Mesenchymal stem cell therapy for liver fibrosis Use of mesenchymal stem cells for therapy of cardiac disease Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions Mechanisms of mesenchymal stem/stromal cell function Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4 Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars.Cardiac Stem Cell Hybrids Enhance Myocardial Repair.Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure.Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.Mesenchymal stem cells are sensitive to bleomycin treatment.Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats.Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis.Cell therapy for liver diseases: current medicine and future promises.Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives.Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process.Bowel Radiation Injury: Complexity of the Pathophysiology and Promises of Cell and Tissue Engineering.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Contribution of dermal-derived mesenchymal cells during liver repair in two different experimental models Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction.Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy.Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation.Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation.Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats.Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies.Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.

P2860

Q26782128-EE9F6F7B-A484-4529-8571-3AC48977DE98 Q27003127-9DCE693B-7604-411D-B9BA-516402EBF5C9 Q28078946-8B285646-AE64-4151-BBA8-65639781C072 Q28079649-08D3A1BD-75E6-47CA-99AC-F970177059E7 Q33625006-DA2AD473-7005-4A9C-BDC2-A503C15006CA Q33722290-685A39FE-1363-4963-883D-2E30923607DE Q33722569-CCA022FA-4BE2-45DF-8CEC-2427C701D2FA Q33842996-31186876-C4B6-407E-B37C-68B85D8823CD Q35596843-7F930B6F-3155-4C6D-8592-20F71AEDC499 Q36030447-1F49971E-3609-4D04-A9E7-EF0A26D5A718 Q36094922-5AE0113B-CB82-44DE-A41D-4AD319D0446E Q36353622-63134615-4F82-4D2C-BEE8-125FB361E06A Q36512529-0F72DCDC-9674-4088-AE73-1D098661ECA2 Q36775830-43C0BA0E-1D0E-4FE4-9C4C-A56B6B0F86FE Q36928779-5878521B-338C-4A47-AD54-369E47858F39 Q37097724-5B73B841-D52C-4D40-A3BD-6CD3E6D2F65D Q37144581-BFB18CA0-D793-4452-A4E1-2AFFFAC5E7C1 Q37172704-762FC892-55DB-40A4-A4E4-40D815FCA8C2 Q38369581-7EF58C57-F1A9-4C8C-867E-71F48D4D8172 Q38395222-0EF19A61-887A-4E77-B629-04989B998D3C Q38835381-42B5FD72-24F2-49D1-85D1-146AD9FD28E1 Q38838522-B9B70018-0F2C-41E8-BBDD-AB4ABD3EF488 Q38874116-45834C1A-8F37-4D4B-92C7-5D6CD0D2238D Q40794119-7A0CA77B-BEB5-4BA8-ADB6-97CD86A86EDF Q42203768-451A16F0-17BA-4ACA-9731-5FAF3D46BA52 Q42368368-302088C3-5CF0-4D7E-9998-DEDEFAAEDEAE Q47159235-13FD4AC2-05F7-49A0-B8AB-D19EAE6B8EC8 Q47585861-C28976EA-7A0C-47EF-9D22-8C820FEFC3F7 Q48162963-3AF8A1A3-D2BF-497D-86C3-4026DF7D2B09 Q48251701-87ECDBAD-0C97-432A-8D44-3C85BD384DAD Q55285430-071EEF93-C4B7-4B12-8748-E10287410607 Q55332824-896CADD3-BD47-4E48-A9E6-76E395F9FF8F Q55401793-269D0B1B-0B8B-4312-A70F-CFD1B6399D9D

P2860

Management of fibrosis: the mesenchymal stromal cells breakthrough

http://www.wikidata.org/entity/Q26827231

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Management of fibrosis: the mesenchymal stromal cells breakthrough

@ast

Management of fibrosis: the mesenchymal stromal cells breakthrough

@en

Management of fibrosis: the mesenchymal stromal cells breakthrough

@nl

type

label

Management of fibrosis: the mesenchymal stromal cells breakthrough

@ast

Management of fibrosis: the mesenchymal stromal cells breakthrough

@en

Management of fibrosis: the mesenchymal stromal cells breakthrough

@nl

prefLabel

Management of fibrosis: the mesenchymal stromal cells breakthrough

@ast

Management of fibrosis: the mesenchymal stromal cells breakthrough

@en

Management of fibrosis: the mesenchymal stromal cells breakthrough

@nl

P1433

Q26827231-78EFEBD3-B84D-40E0-8BA6-F5D693E71D79

P1476

Q26827231-9F83D538-452D-44C1-8248-7DC434B0CE3E

P2093

Q26827231-492BB1FD-D2E6-4869-8708-8786E4C3C790

Q26827231-4B045F5F-A310-4983-ABA1-B4E63A9C5831

Q26827231-B318D76F-880B-4C04-B1B2-EFC4963F421D

P2860

Q26827231-02FDF2C4-9ED3-4916-990A-4BFFD8F936AA

Q26827231-0EBF502F-E08B-4610-AF8C-21CC49689136

Q26827231-13416830-39D3-4523-8E41-D500541DBD11

Q26827231-14466776-CF6B-4176-BE5B-169820B5CE1D

Q26827231-150AC355-BD29-4F3C-A442-348944FDDB14

Q26827231-1DF42FDB-0D93-4BB3-9331-4E57EA71CA5D

Q26827231-25002C49-44D4-4B79-8257-BCDC697B7DF8

Q26827231-293C5272-2582-42CB-9CB1-5852F1579126

Q26827231-2C685400-25F9-457C-ACE4-4F94B2BE81ED

Q26827231-2E10D5A5-FE47-45CF-9C68-7E0B743A9213

P304

Q26827231-919F8CC1-181B-404B-A50E-938AE9672D5B

P31

Q26827231-A91D6127-FC6A-477C-9D81-D8CF02267B1A

P3181

Q26827231-14D46337-4F5A-42CF-946A-3B84593EE5EA

P356

Q26827231-C25CA380-879C-4CC6-9678-3E230A5EBB09

P407

Q26827231-61558E04-5B18-471F-BAF2-03580275F7AB

P478

Q26827231-DB9FB3D9-56C6-406B-8653-0AEA3FC5E74D

P50

Q26827231-51633D30-99FC-4653-818F-675EC5804300

P577

Q26827231-894E508E-778F-4FA4-A5E7-D4AAB3230DEF

P5875

Q26827231-DFC84043-D70E-4560-9DAC-BF76C15910F3

P698

Q26827231-8C05C76C-199E-4699-806B-E5BB1FDE5CFE

P932

Q26827231-ED72057B-064D-4616-A212-AD0AA9606EB5

P3181

P356

P1433

Stem Cells International

P1476

Management of fibrosis: the mesenchymal stromal cells breakthrough

@en

P2093

Benoît Usunier

http://www.w3.org/2001/XMLSchema#string

Marc Benderitter

http://www.w3.org/2001/XMLSchema#string

Radia Tamarat

http://www.w3.org/2001/XMLSchema#string

P2860

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis

Cellular and molecular mechanisms of fibrosis

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

The MOS 36-ltem Short-Form Health Survey (SF-36)

Cellular mechanisms of emerging applications of mesenchymal stem cells

Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)

A model to predict survival in patients with end-stage liver disease

Redox-mediated activation of latent transforming growth factor-beta 1

Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials

P304

340257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1262160

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2014/340257

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265337128

http://www.w3.org/2001/XMLSchema#string

P698

25132856

http://www.w3.org/2001/XMLSchema#string

P932

4123563

http://www.w3.org/2001/XMLSchema#string